By Sheeba M. | April 25, 2026

Federal Rescheduling Progress: De-Risking Cannabis Investments

TL;DR: Recent federal movements toward cannabis rescheduling are reducing regulatory risk for institutional investors. Multi-state operators like Curaleaf and GTI stand to benefit most from banking access and capital market improvements.

Cannabis rescheduling efforts at the federal level are accelerating. If cannabis moves from Schedule I to Schedule III, it unlocks critical advantages for public operators: legitimate bank accounts, federal loan programs, and simplified tax treatment (removing the burden of IRC Section 280E).

The Tax Impact

Under IRC 280E, cannabis companies cannot deduct ordinary business expenses—only COGS. This creates an effective federal tax rate of 70-100% on cannabis revenues. Rescheduling eliminates this handicap. Trulieve Cannabis and other large operators would see immediate bottom-line improvement.

Banking & Capital Markets

Schedule III status opens federal banking. Companies can hold accounts at national banks, reducing reliance on high-fee cannabis banking services. This improves cash flow by 2-5% annually for mid-cap operators. Watch Cresco Labs and Innovative Industrial Properties (REIT model) for upside potential.

Sources

Track cannabis stocks with the Weedstock Real-Time Tracker

Leave a Reply

📅 Yesterday's News & Older Articles →